Large-scale testing (Phase 3)Ended earlyNCT03504917
What this trial is testing
Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label Extension
Who this might be right for
Autism Spectrum Disorder
Hoffmann-La Roche 322
Showing 20 of 0 results